Diseases [C] » Nervous System Diseases [C10] » Central Nervous System Diseases » Brain Diseases » Headache Disorders » Headache Disorders, Primary » Migraine Disorders
Description
A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1) MeSH
Hierarchy View
Subtype Terms (4)
Migraine with Aura
47 drugs (41 approved, 6 experimental)
Migraine without Aura
50 drugs (40 approved, 10 experimental)
Approved Indicated Drugs (48)
Phase 4 Indicated Drugs (48)
Phase 3 Indicated Drugs (25)
Phase 2 Indicated Drugs (55)
Phase 1 Indicated Drugs (19)
Other Experimental Indicated Drugs (67)
Organization Involved with Phase 4 Indications (89)
All India Institute of Medical Sciences
Antalya Training and Govermental Hospital
Beijing Bionovo Medicine Development Co., Ltd.
Birjand University of Medical Sciences
California Medical Clinic for Headache
Haseki Training and Research Hospital
Jiangsu Kanion Pharmaceutical Co., Ltd
Kecioren Education and Training Hospital
Liaoyuan Yulongdongya Pharmaceutical Co., Ltd.
National Center for Advancing Translational Science (NCATS)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institutes of Health (NIH)
Northeast Ohio Medical University
People's Liberation Army of China
State University of New York, Syracuse
Taipei Veteran General hospital
Organization Involved with Phase 3 Indications (75)
Ache Laboratorios Farmaceuticos S.A.
Albert Einstein Israelite Hospital
Centre Hospitalier Sainte-Anne
China National Biotec Group Co., Ltd
Fundação de Amparo à Pesquisa do Estado de São Paulo
Hospital Militar del General Luis Felipe Brieba Aran
Newark Beth Israel Medical Center
New York City Health and Hospitals Corporation
Oregon Health and Science University
Organization Involved with Phase 2 Indications (85)
American Society of Regional Anesthesia
AUTOMATIC SUBDERMAL INJECTOR SYSTEM, INC
Dent Neuroscience Research Center
Hoosier Cancer Research Network
IRCCS National Neurological Institute C. Mondino Foundation
Little Rock Family Practice Clinic
Mercy Health Research / Ryan Headache Center
New England Center for Headache
North Carolina Clinical Research
Northeast Medical Research Associates, Inc.
Renown Institute for Neurosciences - Pringle
St Olavs Hospital, Dept Neurology & Clinical Neurophysiology
Organization Involved with Phase 1 Indications (17)
Organization Involved with Other Experimental Indications (47)
American Academy of Otolaryngology-Head and Neck Surgery Foundation
Case Western Reserve University
Cool Sorption Foundation of 1988
European Institute for Evidence Based Osteopathic Medicine
Federal University of Minas Gerais
Jiaxing Maternity and Child Health Care Hospital
Netherlands Organisation for Scientific Research
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
